Proinsulin processing in the diabetic Goto-Kakizaki rat

in Journal of Endocrinology
Authors:
PC Guest
Search for other papers by PC Guest in
Current site
Google Scholar
PubMed
Close
,
SM Abdel-Halim
Search for other papers by SM Abdel-Halim in
Current site
Google Scholar
PubMed
Close
,
DJ Gross
Search for other papers by DJ Gross in
Current site
Google Scholar
PubMed
Close
,
A Clark
Search for other papers by A Clark in
Current site
Google Scholar
PubMed
Close
,
V Poitout
Search for other papers by V Poitout in
Current site
Google Scholar
PubMed
Close
,
R Amaria
Search for other papers by R Amaria in
Current site
Google Scholar
PubMed
Close
,
CG Ostenson
Search for other papers by CG Ostenson in
Current site
Google Scholar
PubMed
Close
, and
JC Hutton
Search for other papers by JC Hutton in
Current site
Google Scholar
PubMed
Close
View More View Less
Free access

The biosynthesis and processing of proinsulin was investigated in the diabetic Goto-Kakizaki (GK) rat. Immunofluorescence microscopy comparing GK and Wistar control rat pancreata revealed marked changes in the distribution of alpha-cells and pronounced beta-cell heterogeneity in the expression patterns of insulin, prohormone convertases PC1, PC2, carboxypeptidase E (CPE) and the PC-binding proteins 7B2 and ProSAAS. Western blot analyses of isolated islets revealed little difference in PC1 and CPE expression but PC2 immunoreactivity was markedly lower in the GK islets. The processing of the PC2-dependent substrate chromogranin A was reduced as evidenced by the appearance of intermediates. No differences were seen in the biosynthesis and post-translational modification of PC1, PC2 or CPE following incubation of islets in 16.7 mM glucose, but incubation in 3.3 mM glucose resulted in decreased PC2 biosynthesis in the GK islets. The rates of biosynthesis, processing and secretion of newly synthesized (pro)insulin were comparable. Circulating insulin immunoreactivity in both Wistar and GK rats was predominantly insulin 1 and 2 in the expected ratios with no (pro)insulin evident. Thus, the marked changes in islet morphology and PC2 expression did not impact the rate or extent of proinsulin processing either in vitro or in vivo in this experimental model.